Iron Sucrose

Product Description

DAYARAM PHARMA CHEM is one o fthe leading Manufacturer, Exporter, Distributor, and Supplier of Iron sucrose APIand finished formulation of Iron sucrose in Ankleshwar, Gujarat,  India. To understand the largest accomplishment of clients, we present these products at very realistic price ranges. DAYARAM PHARMA CHEM and DAYARAM groupcompanies are nowadays one of the largest manufacturer and exporter of Ironsucrose API and also finished formulations.

DAYARAM PHARMA CHEM is one of leading manufacturer and exporterof Iron sucrose for many years inall the countries like Pakistan, Philippines, Canada, United States, Malaysia,United Kingdom ,Vietnam, Iraq, United Arab Emirates, Bangladesh, Denmark,Malaysia, Kenya, Austria, Norway, Nigeria, Hungary, Hong Kong, Saudi Arabia,Pakistan, Slovakia, Thailand, South Korea, Argentina, South Africa, Iran,Czechia, Israel, Taiwan, Greece, Egypt Romania, Netherlands, Turkey, Poland,Mexico, Spain, France, Italy, Brazil, Japan and many other countries.

DAYARAMPHARMA CHEM provides Iron sucroseto all states of India like Punjab, Rajasthan, Andhra Pradesh, Haryana, Telangana,Bihar, Karnataka, Delhi, Tamil Nadu, Odisha, Maharashtra, West Bengal, UttarPradesh, Gujarat, and Madhya Pradesh etc. We also give gift samples to the companies for R&D purpose.

Iron sucrose is type II complex. Iron sucrose is widelyused in the treatment of iron deficiency anaemia. And it is also used in thetreatment of chronic kidney disease. Iron sucrose comes in injectableformulation which is given by I.V. route.

SYNONYM S: Ferric hydroxide sucrose complex, Iron oxidesaccharated, Iron saccharate, Iron sucrose, Iron sucrose complex, Iron sugar,Saccharated ferric oxide, Saccharated iron, Saccharated iron oxide, Sucroferricoxyhydroxi de 

IUPAC NAME:Pentairon(3+)ion disodium(2R,3R,4S,5S,6R)-2-{[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-trioltrihydrate hydroxide octaoxidandiide

CAS NO: 8047-67-4

FORMULA: C₁₂H₂₉Fe₅Na₂O₂₃

MOLECULAR MASS: 866.55 g/mol

STORAGE CONDITIONS: Store in cool and dry place. Do not put inbathroom or in kitchen. Keep away from children. Place away from direct lightand heat.

HOW TO USE: Iron sucrose given by the injection. Ironsucrose is given by I.V. route. Normally it is given slowly for 2-5 minutes. Itis also mixed with saline solution and given for longer time. The dose of themedicine depends on age, disease condition and treatment response.

HOW IRON SUCROSE WORKS: After the I.V. administration Iron sucrosedissolves in to the blood stream and iron and sucrose will dissociate in blood.The iron will binds with the haemoglobin as cell matures in red blood cells.

PHARMACOKINETICS OF IRON SUCROSE: Iron sucrose will absorbed in body and reachthe high serum levels after the I.V. administration. Iron sucrose only takes 10minutes to reach the peak plasma concentration. Iron sucrose binds with transferringprotein. The half-life of the Iron sucrose is 6 hours. Less than 5% of Ironsucrose is eliminated from the body; the excretion of Iron sucrose is done byrenal rout.

SIDE EFFECTS: The normal side effects of Iron sucrose arenausea, vomiting, muscle cramp, headache, joint pain, back pain, cough,constipation, swelling of legs and arms are normally seen in the patients. Faintingand dizziness also seen some time after giving the dose. See doctor right awayif you see side effects like chest pain, irregular heartbeat, pressure inchest, blurred vision or problem in breathing.

PRECAUTIONS: Tell your doctors if you have are allergic toIron sucrose. Do not take medication if you are in pregnancy. Consult yourdoctor before breast feeding because the medicine passes through the breastmilk.

CDSCO APPROVAL: Iron sucrose injection approved by CDSCO inIndia in 25.03.2004

Iron sucrose complex inj. i.v (finished formulation) approved byCDSCO in India in 02.01.1999

FORMULATIONS AVAILABLE IN MARKET:

Iron sucrose 50 MG tablets

Iron sucrose 500 MG tablets

Iron sucrose injection

Note: Product protected by valid patents are notoffered for sale in countries where such patents are still valid and itsliability is at Buyers Risk